CLSI MM26 Webinar
Leading a Successful and Quality Molecular Oncology Laboratory: Actionable Guidance for Laboratory Directors and Supervisors from CLSI MM26
Date: Thursday, 26 September 2024 | 1:00 PM – 2:15 PM ET
Join CLSI for a webinar focusing on the newly published MM26 Cancer Molecular Testing: Principles of Oncology Test Interpretation, and the topics of Laboratory and Assay Design, and Clinical Consultation. Learn build a cancer testing program and how to maintain and improve a cancer genomics laboratory. Our distinguished speakers will also discuss oncology test interpretation, clinical consultation, and new frontiers in testing. A live Q&A will be available for all your questions about CLSI MM26.
Agenda
- Oncology Test Interpretation and Clinical Consultation | Rong He, MD
- Building and Growing a Cancer Testing Program | Sertac Kip, MD, PhD
- Maintaining and Improving a Cancer Genomics Laboratory and New Frontiers in Testing | Dan Jones, MD, PhD
- Q&A Discussion
Price: Free
Speakers
- Rong He, MD, Hematopathologist and Professor of Laboratory Medicine and Pathology, Mayo Clinic
- Sertac Kip, MD, PhD, Medical Director, Clinical Pathology, PathGroup
- Dan Jones, MD, PhD, Professor and Vice Chair of the Molecular Pathology Section, The Ohio State University
- Honey Reddi, PhD, FACMG, SVP and Medical Director, Belay Diagnostics
Earn 1.25 P.A.C.E.®️ credits. The on-demand recording for this webinar will be available on October 1.
Details
Date of Webinar: September 26, 2024
CLSI MM26 Webinar Additional Details
Learning Objectives
- Appraise the knowledge base required of Molecular Oncology Laboratory Directors for optimal report interpretations and effective communication with clinical stakeholders (oncologists, genetic counselors, other providers).
- Review the elements of building a successful and high-performing laboratory facility and testing and bioinformatics teams to support complex molecular oncology assays.
- Identify best practices for sustainable lab quality and techniques to expand the reach and impact of your molecular oncology laboratory.
CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.